Skip to content

Omeros OMER Free cash flow yield

Free cash flow yield at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-20.5%-5.1pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-9.9%-4.8pp
Immunome logo
ImmunomeIMNM
-8.3%-3.4pp
Vor Biopharma logo
Vor BiopharmaVOR
-17.3%-7.9pp
Annexon logo
AnnexonANNX
-22.2%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-18.1%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

Based on trailing twelve months.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's free cash flow yield?
Omeros (OMER) reported free cash flow yield of -12.7% in Q1 2026.
How has Omeros's free cash flow yield changed year-over-year?
Omeros's free cash flow yield increased by 57.8% year-over-year, from -30% to -12.7%.
What is the long-term trend for Omeros's free cash flow yield?
Over 3 years (2020 to 2025), Omeros's free cash flow yield has grown at a -5.6% compound annual growth rate (CAGR), from -11.3% to -9.5%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.